Kranus Health aims to help men lead healthier and longer lives through access to the latest medical care. Founders Thilo Kleinschmidt and Jens Nörtershäuser have known each other for many years through their time together at McKinsey & Company, and both have been passionate about the possibilities of digital transformation for years. Both also had a keen interest in the health sector. Jens is originally a bio-chemical engineer and has years of professional experience in the pharmaceutical sector. Thilo comes from a medical family, his father is a urologist. So the idea to found Kranus at the beginning of 2020 was obvious and also took place against the backdrop of regulatory changes, especially the Digital Health Care Act (DVG). Since then, it has been possible in Germany to significantly improve healthcare through digital therapies. Professor Kurt Miller, former head physician of urology at Charité Berlin, and CTO Nikolay Dimolarov (Celonis, among others) complement the founding team to jointly implement Kranus' vision. To this end, Kranus Health develops digital therapies based on current scientific findings supported by telemedical care from specialists. The spectrum of services ranges from therapies for taboo diseases such as erectile dysfunction to early detection and prevention (e.g., cardiovascular diseases).
Kranus Health now raised a total of USD 15 million Series A funding to realize its vision of integrated care in urology
Kranus Health closes Series A financing and has now raised a total of 8 million USD for digital men’s health
Kranus Health receives seven-figure Seed investment to revolutionize Men’s Health